We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action spe... Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. Show more
HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024 PR Newswire PLYMOUTH MEETING, Pa., April 16, 2024 PLYMOUTH MEETING, Pa., April 16, 2024 /PRNewswire/...
HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST TPM-1116 preclinical data suggest a potential...
HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME Trial initiation a step toward potentially treating excessive...
HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE PR Newswire PLYMOUTH MEETING, Pa., March 26, 2024 PLYMOUTH MEETING, Pa., March 26, 2024 /PRNewswire/...
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES PR Newswire PLYMOUTH MEETING, Pa., Feb. 28, 2024 PLYMOUTH MEETING, Pa., Feb. 28, 2024 /PRNewswire/ -- Harmony Biosciences...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.53 | 1.84347826087 | 28.75 | 30.14 | 28.14 | 359409 | 29.14428564 | CS |
4 | -4.8 | -14.0845070423 | 34.08 | 34.08 | 28.14 | 389888 | 30.08974895 | CS |
12 | -1.9 | -6.0936497755 | 31.18 | 35.395 | 28.14 | 382621 | 31.49566556 | CS |
26 | 9.82 | 50.4624871531 | 19.46 | 35.395 | 19.03 | 457618 | 29.98333452 | CS |
52 | -2.53 | -7.95347375039 | 31.81 | 39.265 | 18.6112 | 542446 | 31.26324196 | CS |
156 | 1.06 | 3.75620127569 | 28.22 | 62.085 | 18.6112 | 518445 | 38.72700876 | CS |
260 | -7.22 | -19.7808219178 | 36.5 | 62.085 | 18.6112 | 454312 | 38.58239374 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions